Elliott P J, Nemeroff C B, Kilts C D
Brain Res. 1986 Oct 22;385(2):379-82. doi: 10.1016/0006-8993(86)91087-5.
Microinjections of a monoclonal antibody against substance P (SP) into the nucleus accumbens (NAS) increased the concentrations of dopamine (DA) and its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in the NAS but not in neuroanatomically adjacent areas. SP immunoneutralization in the NAS also reduced the locomotor response to systemically administered D-amphetamine. Microinjections of control antibody did not significantly alter either DA metabolism or D-amphetamine-induced locomotion. These data are consistent with the hypothesis that endogenous SP modulates the release of DA in the NAS.
向伏隔核(NAS)微量注射抗P物质(SP)的单克隆抗体,可增加NAS中多巴胺(DA)及其代谢产物3,4 - 二羟基苯乙酸(DOPAC)的浓度,但在神经解剖学相邻区域则无此现象。对NAS进行SP免疫中和,也可降低对全身给药D - 苯丙胺的运动反应。注射对照抗体对DA代谢或D - 苯丙胺诱导的运动均无显著影响。这些数据与内源性SP调节NAS中DA释放的假说相符。